InterviewODwire.org RadioPractice Management

Assembling your Professional Team – Tom Baker, Wells Fargo Practice Finance [#R044]

In this episode, Adam & Paul continue their conversation with Tom Baker, Business Development Manager at Wells Fargo Practice Finance.

When starting a new practice, you need help — and lots of it!

Professionals such as: Lenders, Attorneys, Accountants, Insurance brokers (… and more) are critical to getting your practice off the ground.

We discuss how to assemble your professional team with Tom, and give you tips for finding the right folks.

Ask Tom any follow-up questions in this thread!

Continue Reading
ODwire.org RadioPractice Management

Are You Ready for Practice Ownership? Tom Baker, Wells Fargo Practice Finance [#R043]

In this episode, Adam & Paul talk to Tom Baker, Business Development Manager at Wells Fargo Practice Finance.

Tom has worked with hundreds of practices over the past several decades, and answers questions about how you assess your readiness to dive into your own practice, and the key issues you must address before trying.

Ask Tom any follow-up questions in this thread!

Continue Reading
ODwire.org RadioPractice Management

The Economics of Prokera with Dr. John Rumpakis [#R041]

In this episode, we sit down with Dr. John Rumpakis to discuss the economics of PROKERA®, a biologic corneal bandage composed of preserved amniotic membrane tissue.

Importantly, we’ll learn how to properly bill & code when using this product with your patients.

And if you missed our previous radio show about the clinical aspects of PROKERA®, you can catch it here.

Dr. Rumpakis will be available to take questions in this thread, so fire away!

Continue Reading
InterviewODwire.org Radio

Using the Keratograph 5M to Build your Practice – Dr. Barry Eiden [#R040]

In this episode, we sit down with Dr. Barry Eiden to discuss how he’s built his dry eye practice.

We focus on a particular instrument, the Keratograph 5M, an advanced corneal topographer, and how he uses it to:

  • Evaluate dry eye
  • Track disease progression
  • Educate patients

He discusses tips for building your own dry eye practice, and I ask him a tough question:

Should it be the standard of care to perform a thorough meibomian gland evaluation on all dry eye patients?

(Our thanks again to long-time ODwire.org Supporter OCULUS for sponsoring this show!)

Continue Reading
InterviewODwire.org Radio

Blepharitis, Tea Tree Oil & Cliradex — with Dr. Walter Whitley [#R039]

Blepharitis remains a significant source of discomfort for patients, and over the years docs have tried a variety of therapeutic approaches to treating the problem.

In this ODwire.org Radio show, we talk with Walter O. Whitley, OD, Director of Optometric Services at Virginia Eye Consultants about:

  • The etiology of blepharitis
  • Current therapies
  • The use of tea tree oil
  • Tips to improve patient compliance
  • Dr. Whitley’s experience with Cliradex and in-office treatment with the NEW Cliradex Complete

Please share your experience with ODwire.org members in the thread below, and if you have any questions for Dr. Whitley, ask them here.

Continue Reading

Lewin Survey Finds Large Optometry Surpluses: An Editorial Analysis

Lewin Survey Finds Large Optometry Surpluses: An Editorial Analysis
Kenneth J Myers, Ph.D, OD
October 1, 2014

ODwire.org members may comment on this article here

Lewin Finds:

  • Optometrists Total 39,600 in 2012
  • Optometry Surplus of 12,672 in 2012
  • Future Shortages of Ophthalmologists
  • Replacing Ophthalmologists with Optometrists Still Leaves Large
  • Optometry Surpluses
  • Supply of Eye Care “Providers” is “Adequate”

The author would like to thank his many colleagues who generously took their time to read and comment upon drafts of this paper and Jennifer Spangler, Research Survey Manager at the AOA St. Louis, MO. Office for her assistance. Please address questions, corrections, or comments to myers.kenj@gmail.com.

Executive Summary

The 2012 Lewin National Workforce Survey of Optometrists gathered extensive demographic data about the average optometrist’s practice.

The survey found in 2012 the average optometrist could see 32% more patients (19.8/week) without adding staff or increasing hours reserved for patient care. This was the equivalent of 12,672 full-time surplus optometrists.

Lewin next developed three eye care supply-demand models. Models 1 and 2 ignored the 2012 surplus. Model 3 did not, but assumed a future “total” eye care market in which 1.36 surplus FTE optometrists fill each 1.0 FTE ophthalmologist shortage.

Model 1 (zero 2012 OD surplus) projected a surplus of 3,100 optometrists and a shortage of 5,400 ophthalmologists by 2025.

Model 2 used all surplus optometrists to replace ophthalmology shortages which reduced the ophthalmology shortage from 5,400 to 4,300 in 2025.

Model 3 recognized the 2012 surplus of 12,672 FTE optometrists and projected OD surpluses would fall to 4,400 FTE by 2025 if all ophthalmology shortages were filled with surplus optometrists and demand for eye care increased significantly. If optometrists did not fill all ophthalmology shortages and demand did not increase, the 2025 optometry OD surplus would be about 11,000 FTE.

The OD surpluses and OMD shortages will continue to increase until 2045.

All three Lewin Models are seriously flawed. But the 2012 surplus of 12,672 FTE optometrists found by the Lewin Survey must be addressed to mitigate its damaging effect on younger optometrists burdened by student loan debt.

The Survey found that of those under age 30, 65% practiced at two or more locations as did 40% of those aged 30 to 39. In fact, 11.5% of those under the age of 30 practiced at four locations.

Despite its flawed manpower models, the Lewin Survey report itself provided much needed data on the extent of the optometry surplus and its effect on younger optometrists. That Survey was the first to document there is a surplus of optometrists and to evaluate its impact on younger practitioners as shown by the high percentages of younger optometrists attempting to practice full-time by piecing together two or more part-time practice sites.

But Lewin’s total eye care supply and demand model, that uses the optometry surplus to replace future shortages of ophthalmologists, is highly implausible as explained in this analysis, as it assumes all future shortages of ophthalmology care will be provided by optometrists at the rate of 1.36 optometrists providing the same services as one ophthalmologist.

In the total eye care supply and demand Model 3, Lewin shows a surplus in 2012 of 12,672 optometry FTE that could only decline by 2025 to a surplus of about 4,400 if:

All ophthalmology shortages are filled by optometrists.
There is a large future increase in demand for eye care.
The author believes it more likely the current surplus will grown rather than decline by 2025 due to the untenable nature of the above assumptions.

Finally, thought must be given to the nature of the optometry surplus. The 2012 surplus of 12,672 is distributed across some 40,000 ODs and Lewin’s assumption this surplus FTE pool will be tapped to replace ophthalmology services and thus reduce optometry surpluses somewhat, ignores market place realities and licensing laws.

While a portion of ophthalmology shortages may be filled from the optometry surplus, it is likely those shortages will be filled by greater efficiencies, enhanced technical means and support practitioners affiliated with medical physicians and ophthalmologists. The surplus optometrists will likely remain as entropy within the “optometry market”, in competition with other optometrists which, due to population growth rates of only 0.87% per year, will produce increasing difficulties for younger practitioners attempting to establish viable independent office-based practices.

Lexicon

ACA = Affordable Care Act (Obama Care)

CHI = Children’s Health Insurance

Diabetes Demand = Expected demand for eye care due to its complications

OD = An optometrist

OMD = An ophthalmologist

ODe = A surplus optometrist providing all services of an ophthalmologist
at the rate 1.36 ODe FTE=1.00 OMD FTE.

Lewin Models 2 & 3 solve future shortages of OMDs by
assuming they are all replaced by ODe FTE. A 1.00 OMD
FTE shortage is replaced by (1.36) x (1.00 OMD FTE) = 1.36
ODe FTE using surplus optometry FTE.

Optometrist Defined FTE = In Lewin manpower Models 2 and 3, a hypothetical “total eye care market” is used in which ophthalmology supply and demand is converted into equivalent optometry supply and demand and all shortages of ophthalmologists are filled using surplus optometry FTE. The author uses ODe to refer to surplus optometrist FTE used by Lewin to fill ophthalmology shortages. See below.

D = Density = Numbers of optometrists per 100,000 population

Supply OD FTE = An average OD treating 2,956 patients per year

Supply OMD FTE = An average OMD treating 4,027 patients per year

Supply ODe FTE = A surplus OD FTE seeing 2,956 OMD patients per
year in place of an ophthalmologist [4,027/2,956 =
1.36]

Demand OD FTE = Demand for OD treatments in OD FTE

Demand OMD FTE = Demand for OMD treatments in OMD FTE

Demand ODe FTE = Demand for OMD treatments using ODe FTE
surplus at the rate 1.36 ODe FTE = 1.0 OMD FTE.

Surplus = The amount by which the supply of manpower exceeds the amount of manpower required to equal, or match, the demand or need for that manpower. Lewin measures supply, demand and surplus in “Optometry Defined FTE” in its Model 2 and 3 “total eye care markets”, in which an OD is assumed to supply the same services as an OMD except at the lower rate per year of 2,956 patients.

a, 1 OD FTE = services of one OD at rate of 2,956 patients per year
b, 1 OMD FTE = services of one OMD at rate of 4,072 patients per year
c, 1 Optometry Defined FTE= services of one OD = 1/1.36 = 0.74
OMD FTE = 2,956 ophthalmology or optometry patients per year.

FTE Surplus or Shortage

The surplus, or shortage, of ODs or OMDs expressed in FTEs of supply and demand for each respective provider type. ODe FTE denotes surplus OD FTE used to fill ophthalmology FTE. 1 ODe FTE = 1 OD FTE = 0.74 OMD FTE.

Surplus OD FTE Supply

Lewin’s optometry survey determined an average OD in 2012 could see 19.8 (32%) additional patients/week without additional patient care hours, staff or equipment. This “excess capacity” totaled 12,672 OD FTE in 2012.

Lewin’s Models 1 and 2 assumed the supply of OD FTE in 2012 equaled (matched) demand: ie, there was no surplus of optometrists in 2012.

Lewin’s Model 3, however, used the 2012 surplus OD FTE to fill all ophthalmology shortages which still leaves large future OD surpluses.

Impact of Increased Enrollments on OD
The driving force behind current surplus numbers of practicing optometrists began around 1990 as schools began to enlarge their enrollments and new schools began to open. Surpluses first began to appear around 1995.

For decades, the density D, of optometrists per 100,000, had been at about 10.0 but, by 1997, had reached 11.5 and then 12.8 at the time of the 2012 Lewin National Optometry Survey. This was a 28% increase in numbers of optometrists per 100,000 since 1997, which correlates well with the Lewin finding of a 32% “optometry excess capacity” in 2012. The small difference between 28% and 32% indicates there was “excess capacity” already present in 1997 as the Abt. Survey at that time did not ask optometrists how busy they were and merely assumed supply equaled demand at D=11.5.

The two projections of D beyond 2015 reflect graduation rates of 1,700 or 1,900 per year. Lewin assumed a future rate of 1,800 per year which will
result in D reaching 16.0. The author believes these future D values will create still larger surpluses of optometrists after Lewin’s end point of 2025.

Introduction

A: The Three Lewin Manpower Models.

Understanding the Lewin Eye Care Workforce Study requires careful study because Lewin employs three different, flawed, supply-demand models and makes varying, often unrealistic assumptions which require the reader to pay strict attention as to which projections correspond to which assumptions.

Only Model 3 recognizes an optometrist surplus in 2012, as Models 1 and 2 assume OD supply exactly equaled optometry demand in 2012.

Model 1 assumes zero optometry surpluses in 2012 and projects separate supply-demand data for optometrists and ophthalmologists that show a future OD surplus of 3,100 FTE and a 5,400 FTE OMD shortage in 2025.
[Figures 1, 2 and 3 below]

Figure 1 shows Lewin’s projected numbers of optometrists and resulting lower net FTE by Lewin assuming future entering optometrists would see fewer patients, a questionable assumption since entering optometrists have always seen fewer patients. As a result the Lewin supply projection is not compatible with other studies and underestimates future surpluses.

Figures 2-3 show Lewin Model 1 projections of an optometry surplus of 3,100 FTE and an ophthalmology shortage of 5,400 FTEE by 2025. They each assume zero optometry and ophthalmology surpluses in 2012.

Model 2

Continue Reading
InterviewODwire.org RadioTechnology

Biologic Therapies and PROKERA with Dr. Nick Colatrella [#R038]

Biologic therapies (using substances made from living organisms to treat disease) are the latest cutting-edge tool that you can implement in your practice to improve patient outcomes.

In this ODwire.org Radio show, we sit down with Nick Colatrella, OD, FAAO to discuss:

  • What biologic therapies are
  • How he uses them in his private practice in Minnesota
  • How clinicians who want to get started with biologic therapies can do so & build them into their practices.

We also talk more in-depth with Dr. Colatrella about PROKERA®, a biologic corneal bandage composed of preserved amniotic membrane tissue.

Docs who want to provide leading-edge care to their patients & differentiate themselves should take a listen to this show!

Please discuss your experiences with biologic therapies in the thread below, Dr. Colatrella can answer any follow-up questions here!

Continue Reading
InterviewODwire.org Radio

When Equal is Not Equal: Issues with Prescribing Generic Drugs [#R037]

We’re taught in school that generic drugs are identical to their brand-name equivalents.

But is that true? Are generics actually identical, or do differences in their composition and production processes lead to different clinical outcomes?

In this important ODwire.org Radio show, experienced clinicians Drs. Mel Friedman and Agustin Gonzalez talk about their research into this issue, and what you as a clinician should know when you write for generics vs. branded pharmaceuticals.

If you engage in patient care (or regularly take pharmaceuticals yourself), this is one episode you won’t want to miss!

Continue Reading
InterviewODwire.org RadioPractice Management

Profiting From the Affordable Care Act & Joining an ACO [#R036]

Frequent ODwire.org contributor Dr. Richard Frankel discusses how ODs can profit from the Affordable Care Act, and the nuts-and-bolts of joining an Accountable Care Organization (ACO), which is a critical program for expanding your patient base & ensuring you won’t be left behind.

*** IMPORTANT: The deadline for clinicians joining an ACO & participating in 2015 is August 17, 2014. You need to hurry up & get the process started to avoid being left out.

Listen to the radio show for instructions on how to get started & read the discussion thread.

Continue Reading